Boosted Protease Inhibitors
Once-daily Boosted Fosamprenavir or Atazanavir in Treatment-naive Patients: The ALERT Study   10/06/06

Darunavir/ritonavir plus TMC125 Shows Good Efficacy and Safety in Patients with Resistant HIV   10/03/06

Liver Toxicity Associated with Ritonavir-boosted Tipranavir   10/03/06

Efficacy and Impact on Lipids of Reduced Lopinavir/ritonavir Dosing   10/03/06

Absence of Sex Differences in Fosamprenavir Efficacy and Safety   9/29/06

The KLEAN Study: 48-week Analysis Demonstrates Non-inferiority and Rare Resistance   9/29/06

96-week RESIST Data Show Boosted Tipranavir Produces Superior and Durable Treatment Response   9/29/06







Google_______________



 

 

 

 



 

 

 

 

 


Conference
Main Page